EKF Diagnostics, the in vitro diagnostics company, announces that it will be previewing a new point-of-care (POC) connectivity solution for its range of HbA1c analysers.
EKF will be showcasing the new connectivity package for Quo-Test and Quo-Lab HbA1c analysers, enabling secure bi-directional communication between these POC analysers and a multitude of central data management systems.
Using the industry recognised POCT1-A2 communication protocol, EKF’s connectivity solution unlocks a host of new features aimed at improving security and quality control (QC) for diabetic HbA1c testing.
The new connectivity package includes a proprietary connector interface box, cables and a software upgrade. This enables EKF’s HbA1c analysers to automatically transmit patient data to the majority of Lab Information Management Systems (LIMS) or Hospital Information Systems (HIS).
Traceability and results recall speed are improved by use of patient ID and increased demographic data (such as family name and date of birth). These can now be recorded through either selecting from a pre-approved list or via the barcode scanner and keyboard.
Also ensuring the integrity of results generated at the POC, security and QC is enhanced on Quo-Lab and Quo-Test through user ID and QC lockout functions which are included in the connectivity package.
By restricting access to trained users only, the lockout functions minimize the chances of user error and adhere to security protocols in many institutions. Furthermore, unauthorized users will be prevented from accessing patient information. Multiple user-defined QC lockout options are also available to POCT co-ordinators in order to enforce regular testing of QC materials and ensure compliance.
